Price
No data yet.
Social Signal Score
Revenue
$2.75M+19.86%Company Profile
- CEO
- Anna Elizabeth Biehn
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 40
- Beta
- 1.85
- Country
- CA
- Piotroski score
- 3 / 9 (Weak)
- Altman Z-score
- -1.82
Financials
Revenue
$2.75M+19.9%Net Income
$-2.70M-460.3%EBITDA
$-2.39M-391.0%Free Cash Flow
$-4.50MEPS (diluted)
$-0.85-273.5%Shares Outstanding (diluted)
3.17M+107.9%Operating Expenses
$3.33MCash & Debt
$9.33MReturn of Capital
$43.5KQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2024 | $13.78M | $-15.31M | $-5.93 |
| 2023 | $7.14M | $-3.48M | $-1.89 |
| 2022 | $14.57M | $3.45M | $2.54 |
| 2021 | $13.49M | $2.64M | $1.33 |
| 2020 | $11.86M | $1.46M | $0.85 |
| 2019 | $9.86M | $-867.1K | $-0.48 |
| 2018 | $8.51M | $-231.7K | $-0.13 |
| 2017 | $10.28M | $-762.0K | $-0.43 |
| 2016 | $10.17M | $2.69M | $2.13 |
| 2015 | $7.69M | $3.55M | $3.38 |
| 2014 | $7.66M | $1.37M | $1.21 |
| 2013 | $6.13M | $165.1K | $0.12 |
| 2012 | $5.19M | $-541.1K | $-0.38 |
| 2011 | $5.67M | $565.7K | $0.42 |
Valuation
CSCIhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
80-20.00%Social Signal Score
Mentions (3)
- Newsglobenewswire.com·19d ago·Negative
COSCIENS COMPLETES SECOND TRANCHE OF CONVERTIBLE DEBENTURE OFFERING TORONTO, ONTARIO, Sept. 16, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“COSCIENS” or the “Company”) is pleased to announce, further to the press release dated September 10, 2026, the closing of the second tranche of a non-brokered private placement of the 15% unsecured convertible debentures (the “Offering”).
View source ↗ - Newsaccessnewswire.com·41d ago·Negative
Brightline Interactive Signs Teaming Agreement with CSCI to Support Unmanned Aircraft and eVTOLs for LIFTOff Louisiana, a Test Site Under the FAA eIPP The partnership potentially positions Brightline's flagship SpatialCore platform for its first civilian government application, as the proposed data infrastructure for testing advanced air mobility under the FAA eiPP ASHBURN, VA / ACCESS Newswire / August 26, 2026 / Brightline Interactive, Inc. (NASDAQ:BTLN) today announced entry into a teaming ag…
View source ↗ - Newsglobenewswire.com·55d ago·Neutral
COSCIENS Biopharma Inc. Reports Q2 2026 Results TORONTO, ONTARIO, Aug. 11, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCI.F) (“COSCIENS” or the “Company”) today reported its financial and operating results for the second quarter ended June 30, 2026. All amounts in this press release are in U.S. dollars.
View source ↗
Earnings
Typical surprise +46.8% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Apr 9$-2.15 vs $-3.48beat
- Tue, Nov 12$-1.85 vs $-3.48beat
- Tue, Aug 13$-0.64 vs $-3.28beat
Estimates and results for CSCI via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Congress trades
No disclosed congressional trades in CSCI.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.